Kabra Drugs Ltd , now operating as Aanjaay Industries Limited, concluded its 37th Annual General Meeting on September 30, 2026. The meeting approved audited financial statements for FY26 and ratified the appointment of two new directors.

The AGM was held at Fairfield by Marriott Hotel in Chennai. Mr. K N Anand, Executive Director, chaired the session after being elected by the Board. The Statutory Auditors' report was unqualified, meaning it did not require reading under Section 145 of the Companies Act, 2013.

Resolutions passed

Shareholders voted on four key items of business, covering both ordinary and special resolutions. The remote e-voting facility was active from September 27 to September 29, 2026, prior to the meeting.

Ms. Moonam Kapoor will serve as an Additional Non-Executive Independent Director from April 21, 2026, to April 20, 2031. Mrs. Twinkle Agarwal has been appointed as the company's Practicing Company Secretary for a five-year term spanning FY27 to FY31.

Governance and compliance details

The meeting adhered to SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, and the Companies Act, 2013. M/s. Jay Jain & Associates served as scrutinizers for the voting process. Results of the e-voting and poll were scheduled for announcement within 48 hours post-meeting.

The company noted that all books and records required under the Companies Act were available for inspection during the AGM. The notice convening the meeting was taken as read with member consent.

Aanjaay Industries Limited (formerly Kabra Drugs Limited) returned to profitability in FY26, reporting a net profit of ₹495.98 lakh against a net loss of ₹108.56 lakh in FY25. The turnaround was driven by the resumption of commercial activities, which generated revenue from operations of ₹9,274.00 lakh, compared to nil in the preceding year.

The company’s total expenses stood at ₹8,751.20 lakh, dominated by purchases of stock-in-trade amounting to ₹8,366.40 lakh. This cost structure yielded a gross margin of approximately 9.8%. Other income contributed ₹49.27 lakh to the bottom line, primarily from interest income, while tax expenses were recorded at ₹76.09 lakh.

What the Numbers Show

Despite the accounting profit, the company’s operating cash flow was negative at ₹(946.09) lakh. This divergence stems from a significant increase in trade receivables, which rose to ₹7,077.60 lakh from ₹60.05 lakh in the prior year. While trade payables also increased substantially to ₹5,487.98 lakh, the net working capital requirement absorbed cash generated from operations. Cash and cash equivalents declined to ₹1,058.23 lakh from ₹2,129.93 lakh.

Balance Sheet Position

Total assets expanded to ₹8,631.56 lakh from ₹2,522.90 lakh in FY25. Current assets accounted for ₹8,396.84 lakh, largely driven by the receivable buildup. On the liability side, current liabilities rose to ₹5,658.48 lakh, with trade payables constituting the majority. The company maintained a debt-equity ratio of 0.01, with borrowings limited to ₹42.91 lakh, mostly from directors.

Corporate Developments

The company changed its name to Aanjaay Industries Limited effective July 6, 2026, and shifted its registered office to Chennai. The Board appointed Ms. Moonam Kapoor as an independent director and Mrs. Twinkle Agarwal as secretarial auditor for a five-year term. The 37th Annual General Meeting is scheduled for September 30, 2026.